VTRS.US stock price

Viatris

13.22 USD

+0.18 (+1.38%)

1MN

VTRS.US Key Statistics

Open price

13.04

High today

13.28

Low today

52 Week high

13.46

52 Week low

6.83

Trading hours

-12:00

-11:00

-10:00

-09:00

-08:00

-07:00

-06:00

-05:00

-04:00

-03:00

-02:00

-01:00

UTC 00:00

+01:00

+02:00

+03:00

+03:30

+04:00

+04:30

+05:00

+05:30

+05:45

+06:00

+07:00

+08:00

+09:00

+09:30

+10:00

+11:00

+12:00

+12:45

+13:00

+14:00

UTC 00:00

Symbol trading specification

Trade Viatris

About VTRS.US

Viatris (VTRS.US) reflects investor perceptions of a global pharmaceutical company formed from the merger of Mylan and Upjohn.

What is Viatris?

Viatris is a multinational pharmaceutical firm that produces a wide range of generic, branded, and over-the-counter medications. Its portfolio spans treatments for chronic disease, infectious disease, and biosimilar products. Traders interested in how to trade VTRS.US can begin on a SimpleFX demo account, which enables practicing equities from the S&P500 and healthcare-linked assets without real financial risk. Traders upgrading to a live account can experience no minimum deposit requirement and access the leverage feature to optimize potential returns.

Current VTRS.US stock price

The VTRS.US stock price indicates how Viatris Inc. is valued, a pharmaceutical company formed through the merger of Mylan and Upjohn. The VTRS.US live price is accessible on the SimpleFX website or Webtrader platform.

How does Viatris work?

Viatris operates by manufacturing, marketing, and distributing a vast selection of medicines worldwide through partnerships, licensing deals, and acquisitions. For those investigating how to invest in VTRS.US, it’s essential to monitor drug approvals, patent expirations, and generic competition. On the SimpleFX platform, traders can diversify their portfolios by including global healthcare assets alongside other financial instruments. Viatris’ stock price may depend on regulatory approvals, supply chain dynamics, pricing policies, and patent litigation outcomes.

VTRS.US chart

The VTRS.US chart demonstrates Viatris’ stock dynamics, supported by indicators suitable for structured analysis. The Viatris chart can also be assessed in a demo account reflecting the full version’s analytical framework.

Viatris stock price history

Viatris has experienced varied stock movements influenced by its formation in 2020 from the merger of Upjohn and Mylan. Early valuation was shaped by the integration process and cost-saving initiatives. Subsequent periods have seen fluctuations tied to biosimilar launches, pricing reforms, and generic rollouts.

VTRS.US market cap

Viatris market cap is a key metric highlighting its scale as a global pharmaceutical and generics leader. Monitoring the VTRS.US market cap helps traders understand the firm’s size relative to peers in healthcare and pharma.